The market presents significant opportunities driven by high demand for biologics and protein therapeutics, as well as ...

IBP-9414 will be the first live biotherapeutic product globally, according to officials at Infant Bacterial Therapeutics in Stockholm.

Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center: Our Bureau, Bengaluru ...

Abselion launches His-tagged protein quantification kit and sensors for Amperia, enabling fast, reliable measurement from ...

The global biopharmaceutical market is driven by the rising prevalence of chronic diseases and biotechnology advancements, ...

Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

Global Biopharmaceutical Market OutlookThe global biopharmaceutical market is entering a phase of accelerated expansion, ...

Next-Generation Biologics and Biosimilars Market to Hit 251.13 billion Dollars by 2033 - Strategic Revenue Insights (SRI) ...

The primary rationale for middle-down proteomics is the need for high-confidence proteoform analysis that is also scalable. A proteoform is defined by its full complement of modifications and sequence ...

Precipitation-based purification method could replace current Protein A–reliant methods, significantly reducing manufacturing costs of mAbs.

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia ™ assay portfolio with the launch of its Tagged Protein ...